Monday, October 12, 2026

USD/CHF Bullish By 2% In The Last 10 Sessions

ViaNews Editorial Team

January 23, 2024

USD/CHF Bullish By 2% In The Last 10 Sessions

(VIANEWS) - USD/CHF (USDCHF) has been up by 2.26% for the last 10 sessions. At 03:07 EST on Tuesday, 23 January, USD/CHF (USDCHF) is $0.87.

USD/CHF's yearly highs and lows, it's 4.094% up from its 52-week low and 8.146% down from its 52-week high.

Volatility

USD/CHF's last week, last month's, and last quarter's current intraday variation average was 0.37%, 0.05%, and 0.33%, respectively.

USD/CHF's highest amplitude of average volatility was 0.37% (last week), 0.31% (last month), and 0.33% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/CHF's Forex is considered to be oversold (<=20).

News about

  • Eur/usd price analysis: hovers above 1.0900 followed by the 23.6% fibonacci level. According to FXStreet on Monday, 22 January, "If the EUR/USD pair surpasses the latter, it could approach the major level at 1.0950 followed by the 38.2% Fibonacci retracement level at 1.0957.", "Additionally, the trend-following momentum indicator suggests a confirmation of the bearish trend in the EUR/USD pair as the "Moving Average Convergence Divergence (MACD)" line lies below the centreline and shows a divergence below the signal line."
  • Eur/usd: further downside potential based on the poor economic performance of the eurozone – rabobank. According to FXStreet on Monday, 22 January, "We continue to see risk of EUR/USD pushing lower to 1.0500 on a three-month view."
  • Eur/usd set to trade out something like a 1.0850-1.0960 range near term – ING. According to FXStreet on Monday, 22 January, "Our baseline view sees EUR/USD hanging around these 1.0900 levels as the ECB tries to re-position for a data-dependent approach for future policy."
  • Eur/usd drifts lower as markets gear up for central bank rate call week. According to FXStreet on Monday, 22 January, "Despite bids getting caught up in a near-term congestion pattern, the EUR/USD is notably bullish in the medium-term, with a pattern of higher lows remaining intact and December's swing high into 1.1140 keeping the major pair on the high end.", "The EUR/USD continues to trade into the south end of the 200-hour Simple Moving Average (SMA), slumping below the 1.0900 handle after a brief test above the barrier early Monday."
  • Eur/usd lacks any firm near-term direction, oscillates in a range below 1.0900. According to FXStreet on Tuesday, 23 January, "In the meantime, diminishing odds for an early interest rate cut by the Federal Reserve (Fed) continue to act as a tailwind for the US Dollar (USD) and act as a headwind for the EUR/USD pair. ", "The EUR/USD pair struggles to gain any meaningful traction during the Asian session on Tuesday and oscillates in a narrow trading band below the 1.0900 round-figure mark. "

More news about USD/CHF (USDCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com